innovus pharma files its product license application of vesele in canada as a npn to improvise sexual dysfunction  innovus pharmaceuticals inc otcmktsinnv  seeking alphasign in  join nowgo»innovus pharma files its product license application of vesele in canada as a npn to improvise sexual dysfunctionmay    am etabout innovus pharmaceuticals inc innvby mamta mayani sa news editor innovus pharmaceuticals otcqbinnv announces that the company filed its product license application with health canada as a natural health product npn to commercialize vesele with the indication to “help improve symptoms of sexual dysfunction” if accepted by health canada vesele will be available overthecounter the company will be able to set the retail price like us and will not be reimbursed by the canadian government if approved the company expects to directly launch the product itself if approved by health canada vesele will be the companys fourth product on the canadian market now read neurovive pharmaceutical ab reports q results » stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  am edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest abreakingelon musk details tesla model  pricing range atesla standard model  will cost  longrange model will cost  pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  innv stock price  innovus pharmaceuticals inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states innv overview compare quotes market screener sectors innv us otc join td ameritrade find a broker innovus pharmaceuticals inc watchlist createinnvalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee m pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available the daily startup moda operandi tries on m to push luxury fashion expansion dec   at  am et on the wall street journal recent news other news press releases innovus pharma launches apeaz cream for arthritis pain relief in combination with arthrivarx a supplement designed to maximize and support joint health innovus pharma launches apeaz cream for arthritis pain relief in combination with arthrivarx a supplement designed to maximize and support joint health jul   at  am et on seeking alpha innovus pharmaceuticals innv investor presentation  slideshow innovus pharmaceuticals innv investor presentation  slideshow jun   at  am et on seeking alpha innovus pharma licenses two compounds for use in oncology supportive care innovus pharma licenses two compounds for use in oncology supportive care jun   at  am et on seeking alpha innovus pharma files its product license application of vesele in canada as a npn to improvise sexual dysfunction innovus pharma files its product license application of vesele in canada as a npn to improvise sexual dysfunction may   at  am et on seeking alpha innovus pharmaceuticals innv bassam damaj on q  results  earnings call transcript innovus pharmaceuticals innv bassam damaj on q  results  earnings call transcript may   at  pm et on seeking alpha innovus pharma receives patent for its sensum product in morocco apr   at  am et on seeking alpha innovus pharma nabs european patent for sensum  mar   at  am et on seeking alpha innovus pharma prices equity offering at share mar   at  am et on seeking alpha k innovus pharmaceuticals inc mar   at  pm et on edgar online  edg  q k innovus pharmaceuticals innv ceo bassam damaj on q  results  earnings call transcript mar   at  pm et on seeking alpha innovus pharma launches urivarx for bladder health in the us dec   at  am et on seeking alpha innovus pharma launches zestra in us for fsd nov   at  am et on seeking alpha q innovus pharmaceuticals inc nov   at  am et on edgar online  edg  q k innovus pharmaceuticals innv ceo bassam damaj on q  results  earnings call transcript nov   at  pm et on seeking alpha q innovus pharmaceuticals inc aug   at  pm et on edgar online  edg  q k innovus pharmaceuticals innv ceo bassam damaj on q  results  earnings call transcript aug   at  pm et on seeking alpha innovus pharmaceuticals inks debt deal with institutional investors jul   at  am et on seeking alpha innovus pharma buys testosterone booster maker for k feb   at  am et on seeking alpha premarket biotech digest progenics milestone cellectis conference call alexions strensiq dec   at  am et on seeking alpha innovus pharma inks distribution deal in malaysia dec   at  am et on seeking alpha innovus pharma expands exclusive license and distribution agreement with densmore for zestra® to singapore and vietnam innovus pharma expands exclusive license and distribution agreement with densmore for zestra® to singapore and vietnam jul   at  am et on businesswire  bzx innovus pharma announces combined launch of apeaz™ cream for arthritis pain relief and arthrivarx™ a supplement designed to maximize and support joint health innovus pharma announces combined launch of apeaz™ cream for arthritis pain relief and arthrivarx™ a supplement designed to maximize and support joint health jul   at  am et on businesswire  bzx innovus pharma’s partner luminarie receives approval for zestra® for female sexual arousal disorder as a medical device i from australia’s therapeutic goods administration innovus pharma’s partner luminarie receives approval for zestra® for female sexual arousal disorder as a medical device i from australia’s therapeutic goods administration jul   at  am et on businesswire  bzx the life sciences report examines how a fastgrowing pharma company prepares to launch otc nasal spray the life sciences report examines how a fastgrowing pharma company prepares to launch otc nasal spray jun   at  am et on marketwired innovus joins eli lilly and novartis in the race to develop products for oncology cachexia  secfilingscom innovus joins eli lilly and novartis in the race to develop products for oncology cachexia  secfilingscom jun   at  am et on marketwired innovus pharma to enter the oncology supportive care market with an exclusive license to two graslisted otc compounds for cachexia and muscle growth and repair from the university of iowa research foundation innovus pharma to enter the oncology supportive care market with an exclusive license to two graslisted otc compounds for cachexia and muscle growth and repair from the university of iowa research foundation jun   at  am et on businesswire  bzx innovus pharma announces positive preclinical synergistic effects of vesele® in combination with sildenafil viagra® on nitric oxide production innovus pharma announces positive preclinical synergistic effects of vesele® in combination with sildenafil viagra® on nitric oxide production jun   at  am et on businesswire  bzx innovus pharma launches allervarx a clinically proven supplement for the relief of allergy symptoms in the united states innovus pharma launches allervarx a clinically proven supplement for the relief of allergy symptoms in the united states may   at  am et on businesswire  bzx innovus pharma signs exclusive license and distribution agreement with luminarie in australia new zealand and the philippines for zestra® for female sexual arousal disorder and zestra glide® for female lubrication innovus pharma signs exclusive license and distribution agreement with luminarie in australia new zealand and the philippines for zestra® for female sexual arousal disorder and zestra glide® for female lubrication may   at  am et on businesswire  bzx innovus makes strides toward goal of tripling revenue in   secfilingscom innovus makes strides toward goal of tripling revenue in   secfilingscom may   at  am et on marketwired innovus pharma files its product license application in canada for the commercialization of vesele® as a natural health product to help improve symptoms of sexual dysfunction innovus pharma files its product license application in canada for the commercialization of vesele® as a natural health product to help improve symptoms of sexual dysfunction may   at  am et on businesswire  bzx innovus pharma signs exclusive license and distribution agreement with densmore for zestra® in france and belgium for female sexual arousal disorder innovus pharma signs exclusive license and distribution agreement with densmore for zestra® in france and belgium for female sexual arousal disorder may   at  am et on businesswire  bzx innovus pharmaceuticals reports quarterly revenue for the first quarter  of  million innovus pharmaceuticals reports quarterly revenue for the first quarter  of  million may   at  pm et on businesswire  bzx innovus fast tracks fluticare commercialization with new hikma partnership  secfilingscom innovus fast tracks fluticare commercialization with new hikma partnership  secfilingscom may   at  am et on marketwired innovus pharma announces commercial partnership to launch fluticare™ under fda approved anda no  innovus pharma announces commercial partnership to launch fluticare™ under fda approved anda no  may   at  am et on businesswire  bzx innovus pharmaceuticals to release first quarter  financial results and provide corporate update on friday may   innovus pharmaceuticals to release first quarter  financial results and provide corporate update on friday may   may   at  am et on businesswire  bzx innovus pharma launches prostagorx™ product for prostate health through its beyond human® sales and marketing platform in the united states innovus pharma launches prostagorx™ product for prostate health through its beyond human® sales and marketing platform in the united states may   at  am et on businesswire  bzx global sexual enhancement supplements market  apr   at  pm et on pr newswire  prf innovus pharmaceuticals receives patent for its sensum® product in morocco apr   at  am et on businesswire  bzx innovus pharma announces receipt of notification to commercialize zestra glide® in the european union apr   at  am et on businesswire  bzx innovus pharmaceuticals inc innovus pharmaceuticals inc engages in the commercialization licensing and development of nonprescription medicine and consumer care products for health and vitality and respiratory diseases it also provides packaged healthcare solutions through overthecounter medicines and consumer and health products which it market directly or through commercial partners to primary care physicians urologists gynecologists and therapists and directly to consumers through online channels retailers and wholesalers the company business model leverages the ability to acquire and inlicense commercial products that are supported by scientific and or clinical evidence place them through it existing supply chain retail and online channels the company was founded on january   and is headquartered in san diego ca see full profile competitors name chg  market cap cambrex corp  b merck  co inc  b acelrx pharmaceuticals inc  m horizon pharma plc  b mylan nv  b competitor data provided by partner content trending tickers powered by dvax  s  tsla  ssti  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience innovus pharma mission statement home      careers      contact us     home about us company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet products mens health womens health brain health fertility vitality pain respiratory vision order now investors ir kit tear sheet corporate presentation analyst coverage corporateir events press releases stock information sec filings frequently asked questions key contacts subscribe to email alerts news  media video gallery social media media relations contact   about innovus company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet mission statement innovus pharmas mission is to inlicense acquire or develop overthecounter and consumer healthcare products designed for inhome treatment of medical conditions and ailments to help people take care of themselves and their families in order to live healthy lives         terms of use  privacy policy  sitemap  disclaimer copyright   innovus pharmaceuticals inc all rights reserved innovus pharmaceuticals inc private company information  bloomberg july    am et pharmaceuticals company overview of innovus pharmaceuticals inc snapshot people company overview innovus pharmaceuticals inc a pharmaceutical company engages in the commercialization licensing and development of nonprescription medicine and consumer care products in the united states its products include zestra a proprietary blend of essential oils to enhance desire arousal and satisfaction in women ejectdelay an overthecounter monographcompliant benzocaine gel for premature ejaculation sensum a nonmedicated cream that enhances penile sensitivity zestra glide a waterbased longer lasting lubricant vesele a proprietary oral supplement of arginine sexual and cognitive functions and androferti a natural supplement to support overall male reproductive health and sp innovus pharmaceuticals inc a pharmaceutical company engages in the commercialization licensing and development of nonprescription medicine and consumer care products in the united states its products include zestra a proprietary blend of essential oils to enhance desire arousal and satisfaction in women ejectdelay an overthecounter monographcompliant benzocaine gel for premature ejaculation sensum a nonmedicated cream that enhances penile sensitivity zestra glide a waterbased longer lasting lubricant vesele a proprietary oral supplement of arginine sexual and cognitive functions and androferti a natural supplement to support overall male reproductive health and sperm quality the company also offers beyond human testosterone booster ketones krill oil omega  fish oil vision formula blood sugar colon cleanse green coffee extract and growth agent recalmax for brain health and urivarx a proprietary supplement for overactive bladder and urinary incontinence the company’s pipeline products include fluticare an over the counter drug for rhinitis urocis for urinary tract infection xyralid a lidocaine based cream for the relief of pain and symptoms caused by hemorrhoids allervarx a patented formulation produced in bilayer tablets and androvit a proprietary supplement to support overall prostate and male sexual health the company markets and sells its products through commercial partners to primary care physicians urologists gynecologists and therapists as well as to other healthcare providers and directly to consumers through online channels retailers and wholesalers innovus pharmaceuticals inc was founded in  and is headquartered in san diego california detailed description  towne centre drivesuite san diego ca united statesfounded in  employees phone  fax  wwwinnovuspharmacom key executives for innovus pharmaceuticals inc dr bassam b damaj phd chief executive officer president  director age  total annual compensation k compensation as of fiscal year  innovus pharmaceuticals inc key developments innovus pharmaceuticals inc signs license and distribution agreement with densmore pharmaceutical international for the commercialization of zestrar in singapore and vietnam jul   innovus pharmaceuticals inc announced the signing of an amendment to the exclusive license and distribution agreement with densmore pharmaceutical international for the commercialization of zestrar in singapore and vietnam innovus pharmaceuticals inc announces launch of its first proprietary combination apeaz jul   innovus pharmaceuticals inc announced the launch of its first proprietary combination of an otc monograph drug and a supplement apeaz™ a cream for the relief of arthritis pain and arthrivarx™ a nutritional supplement designed to promote and maximize joint health the products are available through the company’s website and online sites and through its beyond human® platform to the company’s knowledge apeaz™ is the only otc monograph drug published and commercialized to reduce all signs and symptoms of arthritis in a collagen induced mouse model in addition innovus pharma’s proprietary deep penetration formulation was shown to penetrate the joint tissues where the inflammation and joint damage take place j immunol april     supplement  apeaz™ drug facts are available on dailymed apeaz™ arthritis cream is a fast acting fda monograph pain relieving drug and overthecounter medication cream apeaz™ is not only formulated to soothe the pain in joints and muscles like other arthritis and sports creams but it also contains ingredients such as methylsulfonyl methane msm and glucosamine sulfate known to help damaged cartilage for stronger and more pressure resistant joints apeaz™ is indicated to relieve the following acute pain arthritis pain athletic injuries muscle soreness muscle stiffness muscle and joint pain simple backache and strains and sprains innovus pharmaceuticals inc reports earnings results for the first quarter of  prepares to launch otc nasal spray jun   innovus pharmaceuticals inc reported earnings results for the first quarter of  for the quarter the company reported earnings of  million an  increase over first quarter of  the company expects to begin marketing a nasal spray by the end of  fluticare a generic reformulation of flonase nasal spray to provide growth fluticare™ is a fluticasone propionate nasal spray for allergic and nonallergic rhinitis hay feverstuffy nose which innovus has estimated represents more than a  billion market opportunity it is the nasal steroid prescribed in the us with mn units sold since  similar private companies by industry company name region st order pharmaceuticals inc united states st century animal health united states  buds organics llc united states p therapeutics llc united states ° pharmaceuticals llc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact innovus pharmaceuticals inc please visit wwwinnovuspharmacom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close innovus pharma products home      careers      contact us     home about us company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet products mens health womens health brain health fertility vitality pain respiratory vision order now investors ir kit tear sheet corporate presentation analyst coverage corporateir events press releases stock information sec filings frequently asked questions key contacts subscribe to email alerts news  media video gallery social media media relations contact   products mens health womens health brain health fertility vitality pain respiratory vision order now innovus pharma is a leader in otc and clinically proven consumer care products for mens and womens health sexual  reproductive health vitality and respiratory disease explore our mens health product portfolio not all products or indications are available in all countries regulatory requirements in various countries limit the product information that we can provide please read the product label and information prior to using our product and when recommended please consult your physician prior to use these statements have not been evaluated by the food and drug administration this product is not intended to diagnose treat cure or prevent any disease this product is not intended for those with a medical condition use only as directed consult your physician before beginning any prescription drug consult your pediatrician before giving life essentials products to children under  years of age free shipping is to the united states only terms of use  privacy policy  sitemap  disclaimer copyright   innovus pharmaceuticals inc all rights reserved innovus pharma fact sheet home      careers      contact us     home about us company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet products mens health womens health brain health fertility vitality pain respiratory vision order now investors ir kit tear sheet corporate presentation analyst coverage corporateir events press releases stock information sec filings frequently asked questions key contacts subscribe to email alerts news  media video gallery social media media relations contact   about innovus company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet corporate governance code of ethics for officers directors and employees         terms of use  privacy policy  sitemap  disclaimer copyright   innovus pharmaceuticals inc all rights reserved innv stock price  innovus pharmaceuticals inc stock quote us otc  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern a breaking elon musk details tesla model  pricing range a tesla standard model  will cost  longrange model will cost   updated wall street isn’t ready for a point tumble in the dow industrials  barrons buzz robo  facebook and twitter trading on news  a wild week in washington  updated the dark side of cruises  trump to police dont be too nice  updated the highest paid athletes in the world in one chart  updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family  updated here are  coworkers you should avoid like the plague — especially in meetings to be replaced home investing quotes stocks united states innv overview compare quotes market screener sectors innv us otc join td ameritrade find a broker innovus pharmaceuticals inc watchlist createinnvalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta na rev per employee m pe ratio na eps  yield na dividend na exdividend date na short interest na na  of float shorted na average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones no headlines available the daily startup moda operandi tries on m to push luxury fashion expansion dec   at  am et on the wall street journal recent news other news press releases innovus pharma launches apeaz cream for arthritis pain relief in combination with arthrivarx a supplement designed to maximize and support joint health innovus pharma launches apeaz cream for arthritis pain relief in combination with arthrivarx a supplement designed to maximize and support joint health jul   at  am et on seeking alpha innovus pharmaceuticals innv investor presentation  slideshow innovus pharmaceuticals innv investor presentation  slideshow jun   at  am et on seeking alpha innovus pharma licenses two compounds for use in oncology supportive care innovus pharma licenses two compounds for use in oncology supportive care jun   at  am et on seeking alpha innovus pharma files its product license application of vesele in canada as a npn to improvise sexual dysfunction innovus pharma files its product license application of vesele in canada as a npn to improvise sexual dysfunction may   at  am et on seeking alpha innovus pharmaceuticals innv bassam damaj on q  results  earnings call transcript innovus pharmaceuticals innv bassam damaj on q  results  earnings call transcript may   at  pm et on seeking alpha innovus pharma receives patent for its sensum product in morocco apr   at  am et on seeking alpha innovus pharma nabs european patent for sensum  mar   at  am et on seeking alpha innovus pharma prices equity offering at share mar   at  am et on seeking alpha k innovus pharmaceuticals inc mar   at  pm et on edgar online  edg  q k innovus pharmaceuticals innv ceo bassam damaj on q  results  earnings call transcript mar   at  pm et on seeking alpha innovus pharma launches urivarx for bladder health in the us dec   at  am et on seeking alpha innovus pharma launches zestra in us for fsd nov   at  am et on seeking alpha q innovus pharmaceuticals inc nov   at  am et on edgar online  edg  q k innovus pharmaceuticals innv ceo bassam damaj on q  results  earnings call transcript nov   at  pm et on seeking alpha q innovus pharmaceuticals inc aug   at  pm et on edgar online  edg  q k innovus pharmaceuticals innv ceo bassam damaj on q  results  earnings call transcript aug   at  pm et on seeking alpha innovus pharmaceuticals inks debt deal with institutional investors jul   at  am et on seeking alpha innovus pharma buys testosterone booster maker for k feb   at  am et on seeking alpha premarket biotech digest progenics milestone cellectis conference call alexions strensiq dec   at  am et on seeking alpha innovus pharma inks distribution deal in malaysia dec   at  am et on seeking alpha innovus pharma expands exclusive license and distribution agreement with densmore for zestra® to singapore and vietnam innovus pharma expands exclusive license and distribution agreement with densmore for zestra® to singapore and vietnam jul   at  am et on businesswire  bzx innovus pharma announces combined launch of apeaz™ cream for arthritis pain relief and arthrivarx™ a supplement designed to maximize and support joint health innovus pharma announces combined launch of apeaz™ cream for arthritis pain relief and arthrivarx™ a supplement designed to maximize and support joint health jul   at  am et on businesswire  bzx innovus pharma’s partner luminarie receives approval for zestra® for female sexual arousal disorder as a medical device i from australia’s therapeutic goods administration innovus pharma’s partner luminarie receives approval for zestra® for female sexual arousal disorder as a medical device i from australia’s therapeutic goods administration jul   at  am et on businesswire  bzx the life sciences report examines how a fastgrowing pharma company prepares to launch otc nasal spray the life sciences report examines how a fastgrowing pharma company prepares to launch otc nasal spray jun   at  am et on marketwired innovus joins eli lilly and novartis in the race to develop products for oncology cachexia  secfilingscom innovus joins eli lilly and novartis in the race to develop products for oncology cachexia  secfilingscom jun   at  am et on marketwired innovus pharma to enter the oncology supportive care market with an exclusive license to two graslisted otc compounds for cachexia and muscle growth and repair from the university of iowa research foundation innovus pharma to enter the oncology supportive care market with an exclusive license to two graslisted otc compounds for cachexia and muscle growth and repair from the university of iowa research foundation jun   at  am et on businesswire  bzx innovus pharma announces positive preclinical synergistic effects of vesele® in combination with sildenafil viagra® on nitric oxide production innovus pharma announces positive preclinical synergistic effects of vesele® in combination with sildenafil viagra® on nitric oxide production jun   at  am et on businesswire  bzx innovus pharma launches allervarx a clinically proven supplement for the relief of allergy symptoms in the united states innovus pharma launches allervarx a clinically proven supplement for the relief of allergy symptoms in the united states may   at  am et on businesswire  bzx innovus pharma signs exclusive license and distribution agreement with luminarie in australia new zealand and the philippines for zestra® for female sexual arousal disorder and zestra glide® for female lubrication innovus pharma signs exclusive license and distribution agreement with luminarie in australia new zealand and the philippines for zestra® for female sexual arousal disorder and zestra glide® for female lubrication may   at  am et on businesswire  bzx innovus makes strides toward goal of tripling revenue in   secfilingscom innovus makes strides toward goal of tripling revenue in   secfilingscom may   at  am et on marketwired innovus pharma files its product license application in canada for the commercialization of vesele® as a natural health product to help improve symptoms of sexual dysfunction innovus pharma files its product license application in canada for the commercialization of vesele® as a natural health product to help improve symptoms of sexual dysfunction may   at  am et on businesswire  bzx innovus pharma signs exclusive license and distribution agreement with densmore for zestra® in france and belgium for female sexual arousal disorder innovus pharma signs exclusive license and distribution agreement with densmore for zestra® in france and belgium for female sexual arousal disorder may   at  am et on businesswire  bzx innovus pharmaceuticals reports quarterly revenue for the first quarter  of  million innovus pharmaceuticals reports quarterly revenue for the first quarter  of  million may   at  pm et on businesswire  bzx innovus fast tracks fluticare commercialization with new hikma partnership  secfilingscom innovus fast tracks fluticare commercialization with new hikma partnership  secfilingscom may   at  am et on marketwired innovus pharma announces commercial partnership to launch fluticare™ under fda approved anda no  innovus pharma announces commercial partnership to launch fluticare™ under fda approved anda no  may   at  am et on businesswire  bzx innovus pharmaceuticals to release first quarter  financial results and provide corporate update on friday may   innovus pharmaceuticals to release first quarter  financial results and provide corporate update on friday may   may   at  am et on businesswire  bzx innovus pharma launches prostagorx™ product for prostate health through its beyond human® sales and marketing platform in the united states innovus pharma launches prostagorx™ product for prostate health through its beyond human® sales and marketing platform in the united states may   at  am et on businesswire  bzx global sexual enhancement supplements market  apr   at  pm et on pr newswire  prf innovus pharmaceuticals receives patent for its sensum® product in morocco apr   at  am et on businesswire  bzx innovus pharma announces receipt of notification to commercialize zestra glide® in the european union apr   at  am et on businesswire  bzx innovus pharmaceuticals inc innovus pharmaceuticals inc engages in the commercialization licensing and development of nonprescription medicine and consumer care products for health and vitality and respiratory diseases it also provides packaged healthcare solutions through overthecounter medicines and consumer and health products which it market directly or through commercial partners to primary care physicians urologists gynecologists and therapists and directly to consumers through online channels retailers and wholesalers the company business model leverages the ability to acquire and inlicense commercial products that are supported by scientific and or clinical evidence place them through it existing supply chain retail and online channels the company was founded on january   and is headquartered in san diego ca see full profile competitors name chg  market cap cambrex corp  b merck  co inc  b acelrx pharmaceuticals inc  m horizon pharma plc  b mylan nv  b competitor data provided by partner content trending tickers powered by dvax  s  tsla  ssti  chtr  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft innovus pharma home home      careers      contact us     home about us company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet products mens health womens health brain health fertility vitality pain respiratory vision order now investors ir kit tear sheet corporate presentation analyst coverage corporateir events press releases stock information sec filings frequently asked questions key contacts subscribe to email alerts news  media video gallery social media media relations contact   innovus on all social media latest news july    —  innovus pharma expands exclusive license and distribution agreement with densmore for zestra® to singapore and vietnam july    —  innovus pharma announces combined launch of apeaz™ cream for arthritis pain relief and arthrivarx™ a supplement designed to maximize and support joint health july    —  innovus pharma’s partner luminarie receives approval for zestra® for female sexual arousal disorder as a medical device i from australia’s therapeutic goods administration june    —  innovus pharmaceuticals innv investor presentation  slideshow more press releases march   pfizer responds to new york times article on nih policy march   original statement provided to new york times march   pfizer response to global consensus statement on menopausal hormone therapy march   zithromax azithromycin fda drug safety communication more press statements about innovus pharma headquartered in san diego innovus pharma is an emerging overthecounter “otc” consumer goods and specialty pharmaceutical company engaged in the commercialization licensing and development of safe and effective nonprescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases innovus pharma delivers innovative and uniquely presented and packaged health solutions through its a otc medicines and consumer and health products which we market directly b commercial partners to primary care physicians urologists gynecologists and therapists and c directly to consumers through our online channels retailers and wholesalers the company is dedicated to being a leader in developing and marketing new otc and branded abbreviated new drug application “anda” products the company is actively pursuing opportunities where existing prescription drugs have recently or are expected to change from prescription or rx to otc our mission statement innovus pharmas mission is to inlicense acquire or develop overthecounter and consumer healthcare products designed for inhome treatment of medical conditions and ailments to help people take care of themselves and their families in order to live healthy lives new products vesele clinically tested to enhance sexual health endpoints    learn more » androferti®  the only product clinically proven to increase the sperm quality    learn more » recalmax®  promotes healthy brain function    learn more » get the latest deals and promotions visit shopinnovuspharmacom future events there are currently no events scheduled terms of use  privacy policy  sitemap  disclaimer copyright   innovus pharmaceuticals inc all rights reserved innovus pharma contact us home      careers      contact us     home about us company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet products mens health womens health brain health fertility vitality pain respiratory vision order now investors ir kit tear sheet corporate presentation analyst coverage corporateir events press releases stock information sec filings frequently asked questions key contacts subscribe to email alerts news  media video gallery social media media relations contact   about innovus company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet contact us innovus pharma investor relations irinnovuspharmacom t   transfer agent interwest transfer co inc   murray holladay road suite  salt lake city ut  t   infointerwesttccom innovus pharmaceuticals inc   towne centre drive ste  san diego ca  t   f   innovus pharma customer service toll free in the us  you may use this form to subscribe to receive innovus pharmaceuticals press releases news events and other updates fields marked with a red asterisk  are required contact form first name  last name  email address  telephone number comments  terms of use  privacy policy  sitemap  disclaimer copyright   innovus pharmaceuticals inc all rights reserved innovus pharmaceuticals inc innv stock message board  investorshub support   newswire  home  log in boards stocks commodities forex cryptocurrency the lounge hot breakout boards ihub my stocks activity ticker buzz cloud most read most posted most followed members recent news active boards site stats new boards cannabis stocks tools data tools  charts trader alerts trades portfolio top lists price  news alerts commodities markets in d newswire more tools  newsletters my image gallery advanced search videos all news stock screener news filter live charts live news live desktop forex prices commodities etf center educational channel personal finance qa streamer level  follow feed home  boards  us otc  biotechs  innovus pharmaceuticals inc innv add innv price alert      hide sticky   hide intro moderator boodog kkpennies cash peter lynch pharmacyman search this board                 created   am  followers   board type free  posts today     httpwwwinnovuspharmacom httpstwittercominnovuspharma httpshopinnovuspharmacom  shareholders please consider purchasing products alert awaiting official announcement of fda approval for fluticare   fluticare™ approval could bring a billion dollars in sales annually redondo beach camarketwired  jul    secfilingscom a leading financial news and information portal offering free real time public company filing alerts discusses the potential impact of the anticipated fda ruling on innovus pharmaceuticals otcqb innv anda filing for fluticare™ the companys overthecounter treatment for allergic rhinitis fluticare™ is designed to treat nonallergic rhinitis  better known as hay fever or stuffy nose  which affects roughly  million americans each year while  of these individuals use overthecounter products more than half are not satisfied with the treatment option according to an asthma and allergy foundation of america survey which suggests theres an opportunity for a prescriptionstrength otc treatment option to capture market share from category leaders as the  prescription nasal steroid with over  million units sold since  innovus believes that the overthecounter version of fluticare™ could be worth up to  billion per year by addressing a much wider overthecounter market the fda decision is expected in the next several weeks     the ceo has already signed an agreement for the manufacturing of fluticare   innovus pharma achieves major milestone with securing a manufacturing agreement for fluticare in anticipation of the fda decision san diego camarketwired  may    innovus pharmaceuticals inc innovus pharma otcqb innv an emerging commercial stage pharmaceutical company that delivers safe innovative and effective overthecounter medicine and consumer care products to improve men and womens health and respiratory diseases today announced that it signed a manufacturing agreement for the supply of its fluticare™  and  spraybottles  innovus signed the agreement in anticipation of the fdas decision expected between julyseptember of this year on the anda application for the drug     prior to joining innovus pharma dr damaj served as president and chief executive officer of apricus biosciences inc  where he helped move the companys stock price from  cents to   uplisted from otc to nasdaq      company profile headquartered in san diego innovus pharma is an emerging leader in otc and consumer products for mens and womens health and vitality the company generates revenues from its lead products a bth® testosterone booster b bth® human growth agent c zestra® for female arousal and d ejectdelay® for premature ejaculation and has an additional five marketed products in this space including e sensum® for the indication of reduced penile sensitivity for sales outside the us only f zestra glide® gvesele® for promoting sexual and cognitive health i androferti® in the us and canada to support overall male reproductive health and sperm quality j bth vision formula k bth blood sugar among others and eventually fluticare™ otc for allergic rhinitis if its anda is approved by the us fda business summary innovus pharmaceuticals inc a pharmaceutical company engages in the commercialization licensing and development of nonprescription medicine and consumer care products in the united states its products include zestra a nonmedicated patented consumer care product to enhance desire arousal and satisfaction in women ejectdelay an overthecounter monographcompliant benzocainebased topical gel for treating premature ejaculation sensum a nonmedicated consumer care cream that enhances penile sensitivity zestra glide a high viscosity and low osmolality waterbased lubricant vesele a proprietary oral dietary supplement to enhance nitric oxide beneficial clinical effects on sexual functions and brain health and androferti to support overall male reproductive health and sperm quality the companys pipeline products includes fluticare an over the counter drug for rhinitis urocis for urinary tract infection and androvit a proprietary supplement to support overall prostate and male sexual health the company markets and sells its products through commercial partners to primary care physicians urologists gynecologists and therapists and directly to consumers through online channels retailers and wholesalers innovus pharmaceuticals inc was incorporated in  and is based in san diego california bassam damaj phd president and chief executive officer dr bassam damaj was appointed to serve as our president and chief executive officer in january  prior to joining innovus pharma dr damaj served as president and chief executive officer of apricus biosciences inc nasdaq apri a specialty pharmaceutical company from december  until november  at apricus bio dr damaj was responsible for the approval of its lead drug vitaros a treatment for erectile dysfunction dr damaj also signed multimillion dollar partnerships between apricus bio and leading pharmaceutical companies such as abbott novartissandoz and takeda before apricus bio dr damaj was a cofounder of bioquant inc and served as the chief executive officer and chief scientific officer and a director of bioquants board of directors from its inception in june  until its acquisition by apricus biosciences in december  in addition dr damaj was the founder chairman president and chief executive officer of rd healthcare and the cofounder of celltek biotechnologies he also served as a director of the board of directors at creagri inc and was a member of the scientific advisory board of microislet inc he is the author of the immunological reagents and solutions reference book the inventor of many patents and author of numerous peer reviewed scientific publications dr damaj won a us congressional award for the anthrax multiplex diagnostic test in  dr damaj holds a phd degree in immunologymicrobiology from laval university and completed a postdoctoral fellowship in molecular oncology from mcgill university   who are the major players at innovus pharma   share structure shares outstanding      million as of    dr damaj owns m shares  novalere owns m  one person and one entity own   of the outstanding shares   profitability expected exiting q     projected revenue of m not counting fluticare which would be approximately x greater than       products httpswwwooyessbargains httpwwwinnovuspharmacomproductsotcmhphptop company videos innovus pharma ceo provides shareholder update and conference call httpfinanceyahoocomnewsinnovuspharmaceoprovidesshareholderhtml httpswwwyoutubecomwatchvftmpoimqu httpswwwyoutubecomwatchvwfkfrasjy httpswwwyoutubecomwatchvfynqjvlvg httpswwwyoutubecomwatchvmqmdywzs corporate presentation november  k   httpclientirwebkitcominnovuspharmafilingsqmpage upcoming pdufa and anda approval dates could catalyze innovus pharma innv and lipocine lpcn httpfinanceyahoocomnewsupcomingpdufaandaapprovaldateshtml innovus pharma innv targeting  billion markets with  commercial products httpfinanceyahoocomnewsinnovuspharmainnvtargetinghtml major  accomplishments     where can innv products be seen   existing product lines  innovus pharma httpshopinnovuspharmacom newest product httpwwwprostagorxcom what is prostagorx™ prostagorx™ is a clinical strength multi response prostate supplement scientifically formulated to effectively maintain good prostate health and help in prevent prostate issues in the future prostagorx™ was developed by top medical doctors and produced in a topquality cgmp certified and fda registered laboratory environment under the most rigorously professional conditions  the positive benefits provided by the individual and combination ingredients in prostagorx™ have been published in leading medical journals  r                httpwwwrecalmaxcom httpwwwurivarxcom httpwwwmyandroferticom httpswwwmyveselecom httpswwwooyessbargains  help to get the word out and be a product ambassador for your company innv current price volume bid ask days range innv detailed quote dmmmmyyyy innv news statement of changes in beneficial ownership    am innv news statement of changes in beneficial ownership    am innv news statement of changes in beneficial ownership    am innv news current report filing k   am innv news current report filing k   am post new msg follow board my stocks  hide intro view posters innv poststream bans  hide quote filter disabled postsubject older    innv improving we can handle it figure boodog   am    heavily shorted almost  mil shares looking to cover cash   am    innovus pharma announces receipt of notification to commercialize kkpennies   pm    trump twister two big brothers  healthywelth   am    this stock is over never see cents again trumpforpres   pm    httpswwwyoutubecomwatchvpfydszewha twistedfreak   pm    like i said they are on the sec twistedfreak   pm    just have to wait another two to three shawnp   pm    now is down  hahaha the bid and trumpforpres   pm    grown man highly doubtful sounds more like a batermere   pm    just showing that with some decent volume this boodog   pm    not for me it isnt im still up batermere   pm    no i like it here at the damaj twistedfreak   pm    im not worried go cry about it somewhere else batermere   pm    buy more help damage paying his salary with trumpforpres   pm    the bids at  its all that matters twistedfreak   pm    right and innv is up  on a batermere   pm    excited about k blocks on a dime stock twistedfreak   pm    look at all those ks lined up straight boodog   pm    all major stocks are posting killer earnings while trumpforpres   am    bang a gong by t rex what a batermere   pm    yep im averaged in at  locked and mwilson   pm    good shape here imo the potential is leading boodog   pm    tt we are in a holding pattern awaiting batermere   pm    so where are all these shares coming from pumpers truetrades   pm    just dont wake up trumpforpres   pm    yawn i think im gonna go take a nap mwilson   pm    facebook page of zestra trumpforpres   pm    looks like the constant effort to reveal who trumpforpres   pm    i would have sold if they focused all trumpforpres   pm    might have to pick some up on my boodog   pm    this co could have turned a profit on truetrades   pm    if innv had much going in revs they shawnp   pm    doesnt look like the market considers the releases shawnp   pm    nice try  keep dreaming  its free healthywelth   pm    let me make another k off of this batermere   pm    agreed the sec should completely shut off this trumpforpres   pm    i went off the cliff at  and twistedfreak   am    i dont see any runup into some great truetrades   am    all your negative team goesoff the healthywelth   am    yes yes you are imo this is going twistedfreak   am    we are so lucky to have you kkpennies   am    yep nitrous and percodan life is good innv batermere   am    dogs barking to get the drunk caravan drivers twistedfreak   am    now we stretching q  gtfo dude answer trumpforpres   am    great news mwilson   am    absolutely damaj is doing a great job looking batermere   am    dogs barking  but caravan goes  healthywelth   am    th quarter into  is looking much better imo boodog   am    theres another  million in revenues in the batermere   am    innovus pharma expands exclusive license and distribution agreement boodog   am    another garbage news keep pumping that zestra all trumpforpres   am    yep boodog christmas allergy season fluticare will blast twistedfreak   am postsubject older post new msg follow board my stocks  hide intro view posters innv poststream bans  hide quote filter disabled   investorshubcom inc about investor relations about us terms of service privacy policy advertise with us data accreditations disclaimer help faq handbook qa forum contact us tutorials educational educational channel stock market  educational videos investor help forum personal finance qa more corporate solutions ihub on facebook ihub on twitter ihub iphoneipad app ihub android app ihub blackberry app ihub newswire you are guest on web   microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft innovus pharmaceuticals inc innvotcqb streetwise reports the gold report the energy report the life sciences report the gold reportthe energy reportthe life sciences report innvotcqb innovus pharmaceuticals inc innovus pharma inc is an emerging over the counter otc consumer goods and specialty pharmaceutical company engaged in the commercialization licensing and development of safe and effective nonprescription medicine and consumer care products to improve men and womens health and vitality and respiratory diseases innovus delivers innovative and uniquely presented and packaged health solutions through its otc medicines and consumer and health products which markets directly with commercial partners to primary care physicians urologists gynecologists and therapists and consumers through our online channels retailers and wholesalers the company is dedicated to being a leader in developing and marketing new otc and branded abbreviated new drug application products innovus is actively pursuing opportunities where existing prescription drugs have recently or are expected to change from prescription to otc read more innvotcqb view company news visit company website expert comments fastgrowing pharma company prepares to launch otc nasal spray  a san diegobased pharmaceutical company that focuses on overthecounter medications reported strong q results and expects to begin marketing a nasal spray by the end of the year read more  ajay tandon seethruequity  innovus pharmaceuticals inc recently released robust top line results in q  revenues rose by  to m in q versus m in q  gross margins remained at attractive levels at  allowing the company to cash burn and target profitability  innovus issued reiterated its target for mn  mn in sales for e which would imply  to  growth over  revenues of m  we are updating our price target to   innovus represents a compelling growth company in the healthcare space with a management team that has demonstrated its ability to execute on sales growth ajay tandon seethruequity  innovus pharmaceuticals inc reported q results which showed an improvement in revenues and gross margins on both a sequential and yearoveryear basis revenues rose by  over q and more than  sequentially to mn as compared to mn in q and mn in q respectively  we see several potential catalysts for the company over the next year stemming from new products such as fluticare and urox as well as the company potentially reaching recurring adjusted profitability in e additionally management continues to discuss uplisting shares to a national exchange which could also serve as a catalyst given the potential for increased liquidity and access to more institutional investors amit tandon seethruequity  we were enthused by q results and outlook at innovus pharmaceuticals inc which clearly showed the company is in growth mode and thus far has been able to integrate the beyond human without major setbacks innovus reported strong numbers in q that seemed to reflect early success with the beyond human product line and its sales and marketing platform  we were impressed to see innovus guide to revenues of m for  which was well ahead of our estimate of m  the main swing factors for innovus outlook are the pace of adoption of new products entering commercialization more expert comments amit tandon seethruequity  innovus pharmaceuticals inc recently completed the acquisition of beyond human which has expanded its pipeline to include  commercialized products and three pipeline products and has several upcoming key milestones on the horizon including fluticare innovus management expects to hear from the fda regarding its anda for fluticare which is perhaps the crown jewel of the companys pipeline targeting what innovus estimates is a b potential opportunity  innovus appears to be making progress in the early stages of commercialization given that innovus has stated that it has signed eight commercial partnerships with over m in sales milestones plus royalties in  countries amit tandon seethruequity  innovus pharmaceuticals inc completed what appears to be a wellconceived and potentially transformative strategic move on march   with the acquisition of revenue generating assets of beyond human the move will add scale and accelerate the companys push towards achieving profitability  potentially as soon as   with the acquisition of assets of beyond human innovus now has  commercial products and  pipeline products targeting a  billion market opportunity in mens and womens health and vitality and respiratory disease experts following this company ajay tandon ceo – seethruequity amit tandon director of research – seethruequity the information provided above is from analysts newsletters the company and other contributors innovus pharmaceuticals inc is a sponsor of streetwise reports the companys sponsorship fees pay for streetwise reports to create and update this investor summary page to which links are placed on streetwise reports websites and newsletters streetwise reports does not accept stock for the payment of fees see disclaimer for more details the company description investing highlights and catalyst calendar on this page were prepared by the company the expert comments and experts following this company sections of this page are compiled by streetwise reports there may be other information about the company that is not placed on this page streetwise reports does not guarantee the accuracy or thoroughness of the information contained on this page the expert opinions above are excerpted from thirdparty sources not affiliated with or controlled by streetwise reports the statements or opinions expressed in the expert opinions above are those of the authors indicated and streetwise reports has not verified the accuracy of material excerpted here streetwise reports does not provide investment advice and the information on streetwise reports should not be considered a recommendation to buy or sell any securitystreetwise reports does not endorse or recommend the business products services or securities of any company mentioned on streetwise reports readers should conduct their own research for all information publicly available concerning the company investing highlights   launching fluticare in q  which will only be the third nationally branded fluticasone propionate spray in the market   revenue growth potential of over  in  and then over  again in    continuing to execute on our goal of becoming profitable exiting  catalyst calendar launching fluticare in q  launching fluticare in q  which will only be the third nationally branded fluticasone propionate spray in the market completion of human clinical trials on effects of vesele   completion of human clinical trials on effects of vesele combined with sildenafil viagra® and tadalafil cialis® in  q projected to be profitable exiting q  q launching fluticare in q  q completion of human clinical trials on effects of vesele   innovus pharmaceuticals inc content corporate presentation video gallery subscribeaboutdisclaimercontactsponsorshipsyndicationcareerspolicies   streetwise reports all rights reserved streetwise reports is registered with the us patent and trademark office innovus pharma fact sheet home      careers      contact us     home about us company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet products mens health womens health brain health fertility vitality pain respiratory vision order now investors ir kit tear sheet corporate presentation analyst coverage corporateir events press releases stock information sec filings frequently asked questions key contacts subscribe to email alerts news  media video gallery social media media relations contact   about innovus company profile management team board of directors board committee charters advisory board clinical advisory board mission statement careers fact sheet corporate presentation innovus pharma corporate presentation – june  you will need to have the adobe® acrobat reader installed on your computer to view these documents you can download a copy of the adobe® acrobat reader by clicking the icon below         terms of use  privacy policy  sitemap  disclaimer copyright   innovus pharmaceuticals inc all rights reserved innovus pharmaceuticals receives patent for its sensum® product in moroccohomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballinnovus pharmaceuticals receives patent for its sensum® product in moroccobusiness wireapril  reblogsharetweetsharesan diegobusiness wireinnovus pharmaceuticals inc innovus pharma or the “company” otcqb venture market innv an emerging overthecounter “otc” consumer goods and specialty pharmaceutical company engaged in the commercialization licensing and development of safe and effective nonprescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases today announced that it has received a patent from the moroccan patent office entitled “sensitization composition and method of use” for the company’s sensum® product for reduced penile sensitivity the moroccan patent is scheduled to expire on march   this is the second major international patent notification that innovus pharma has received on its sensum® product in the last thirty days the first being the company’s receipt of a notice of intention to grant a patent for all  countries of the european union announced on march  innovus pharma has also previously filed patent applications for its sensum® product in australia brazil china israel japan mexico new zealand and south korea“i am very excited about the continuous and broader coverage for one of our important core products” said dr bassam damaj the president and chief executive officer of innovus pharma “we are looking forward to increasing our international patent portfolio for this product and in helping our distributors to launch this product in certain overseas markets in the future”about sensum®sensum® is a nonmedicated cream which moisturizes the head and shaft of the penis for enhanced feelings of sensation and greater sexual satisfaction it is a patented blend of essential oils and ingredients generally recognized as safe that recently commenced marketing in the us innovus pharma acquired the global exus distribution rights to sensum® from centric research institute the safety and efficacy of sensum® was evaluated in two postmarketing survey studies in circumcised and noncircumcised men a total of  men used sensum® twice daily for  consecutive days followed by once daily for eight weeks and as needed thereafter study participants reported a  increase in penile sensitivity with the use of sensum®about innovus pharmaceuticals incheadquartered in san diego innovus pharma is an emerging overthecounter “otc” consumer goods and specialty pharmaceutical company engaged in the commercialization licensing and development of safe and effective nonprescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases innovus pharma delivers innovative and uniquely presented and packaged health solutions through its a otc medicines and consumer and health products which the company markets directly b commercial partners to primary care physicians urologists gynecologists and therapists and c directly to consumers through its online channels retailers and wholesalers the company is dedicated to being a leader in developing and marketing new otc and branded abbreviated new drug application “anda” products the company is actively pursuing opportunities where existing prescription drugs have recently or are expected to change from prescription or rx to otcinnovus pharmas forwardlooking safe harborstatements under the private securities litigation reform act as amended with the exception of the historical information contained in this release the matters described herein contain forwardlooking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the company including but not limited to the company’s need for additional equity or debt financing to receive applicable regulatory approval for its products successfully commercialize sensum® in morocco and other products in other countries and to achieve its other development commercialization financial and staffing objectives readers are cautioned not to place undue reliance on these forwardlooking statements as actual results could differ materially from the forwardlooking statements contained herein readers are urged to read the risk factors set forth in the companys most recent annual report on form k and other filings made with the sec copies of these reports are available from the secs website or without charge from the companyview source version on businesswirecom httpwwwbusinesswirecomnewshomeenreblogsharetweetsharerecently viewedyour list is emptywhat to read nextshkreli portrayed as con prodigy at securities fraud trialassociated pressthis will be in everyones household by banyan hillsponsoredhow fentanyl is making the opioid epidemic even worsevoxjeff bezos’ brief stint as world’s richest human ends with amazon’s secondquarter whifftechcrunchab inbev bud earnings and revenues miss estimates in qzacksengineer finds pattern makes millions in stocksmoney morningsponsoredthe senate probe into big pharmas hand in the opioid crisis just got biggerbusiness insiderthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insiderthe real reason overseas manufacturing is coming to americayahoo financediscover it  out of  avg by k customersdiscover cardsponsoredhere are the us targets north korea most likely wants to nukebusiness insiderchevron and exxon mobil have a tough path ahead nyse traderyahoo finance videostocks mixed after heavy earnings weektrunk club making sense of styletrunk clubsponsoredtrump to cops please dont be too nice while arresting thugs and dont worry about their heads when you toss them in the paddy wagonbusiness insiderwells fargo faces angry questions after new sales abuses uncoveredreutersnorth korea says nd icbm test puts entire us in rangejohn doesnt that little fat kid know that if he actually fires a missile at something other than water his country will just be annihilatedjoin the conversation  k bbb business profile  innovus pharmaceuticals inc home    business directory    pharmaceutical products  wholesale  manufacturing    innovus pharmaceuticals inc this business is not bbb accredited innovus pharmaceuticals inc submit a review innovus pharmaceuticals inc business information   innovus pharmaceuticals inc  years in business headquarters  towne centre dr  san diego  ca  email website fax numbers   additional email addresses infoinnovuspharmacom additional website addresses httptrybeyondhumancom httpwwwejectdelaycom httpwwwsensumpluscom httpwwwmyveselecom httpwwwzestracom httpwwwzestracomglide httpmyandroferticom httptrybeyondhumancomproductbloodsugarsupport httpwwwapeazcom httpwwwxyralidcom httpsshopinnovuspharmacom see less contact options see more contact options find a location bbb file opened  business started  business incorporated  in nv type of entity corporation business category pharmaceutical products  wholesale  manufacturing products  services multiple service area san diego county ca alternate business names beyond human testosterone sensum beyond human growth agent vesele zestra zestra glide androferti blood sugar support omega  fish oil epadha eagle vision krill oil eagle vision colon cleanse lean green coffee innovus pharma apeaz ultra xyralid fluticare eagle vision formula see more alternate business names see less alternate business names methods of payment credit cards po checks wire transfer paypal refund  exchange policy  any claim for credit or return goods request must be made within thirty  days of receipt and require a return merchandise authorization rma number please email us at veselecustomerserviceinnovuspharmacomthis email address is being protected from spambots you need javascript enabled to view it  or call customer service at  from  am –  pm est monday through friday to receive a rma number upon receipt of authorized returned products a refund for the original purchase price less the original shipping and handling charge partial refund will be issued to obtain a partial refund products must be returned within thirty  days of receiving an rma number see less business information see more business information business information f bbb rating scorecard advertising review on february   bbb asked the business to substantiate claims that while using its product participants frustrated with their memory experienced an average  boost in brain power and had  increase in their processing speed and brainpowera  lift in memory strength  increase in clearer thinking improvement in concentration and a massive  boost in mental energy advertisers must be prepared to substa read more advertising review on february   bbb asked the business to substantiate claims that while using its product sensum  cream double even triple your penile feeling and sensation and clinical studies prove sensum ends these common male sexual problems fast and effectively the result of two clinical studies on men both circumcised and not show sensum  more than doubled penis sensitivity and more than tripled sexual satisfaction  advertisers must be read more overview this company offers diet and health product services  share your experience submit a review submit a complaint bbb reason for ratings bbb rating is based on  factors get the details about the factors considered factors that affect the rating for innovus pharmaceuticals inc include  complaints filed against business failure to respond to  complaints filed against business advertising issues found by bbb bbb reports on licensing licensing information is provided in the bbb business profiles to inform the public about industries that may require professional licensing bonding or registration better business bureau encourages you to check with the appropriate agency to be certain any requirements are currently being met advertising review bbb promotes truth in advertising by contacting advertisers whose claims conflict with the bbb code of advertising these claims come to our attention from our internal review of advertising consumer complaints and competitor challenges bbb asks advertisers to substantiate their claims change ads to make offers more clear to consumers and remove misleading or deceptive statements government actions bbb reports on known significant government actions involving the businesss marketplace conduct out of business bbb reports on a company that is out of business for three years from the date the company closes its doors or ceases to do business misuse of better business bureau namelogo bbb reports on unauthorized use of the better business bureaus name andor logo for as long as the business continues to use it in any advertising or for one year after the business ceases any repeated unauthorized uses bankruptcy bbb reports on a business’s bankruptcy as long as the business remains in bankruptcy mail returned bbb reports when mail sent to the business was returned by the postal service innovus pharmaceuticals inc bbb rating scorecard this business is not bbb accredited innovus pharmaceuticals inc f bbb rating system overview customer review rating the bbb customer review rating represents the customers opinion of the business the customer review rating percentages are based on the total number of positive neutral and negative reviews posted   positive reviews  neutral reviews  negative reviews  total customer reviews  total customer complaints composite score innovus pharmaceuticals inc has received  out of  stars based on  customer reviews and a bbb rating of f comprised of  bbb rating and  customer review rating the bbb customer review rating represents the customers opinion of the business the customer review rating percentages are based on the total number of positive neutral and negative reviews posted the bbb letter grade represents the bbbs opinion of how the business is likely to interact with its customers the bbb grade is based on bbb file information about the business in some cases a business grade may be lowered if the bbb does not have sufficient information about the business despite bbbs requests for that information from the business the bbb customer review rating plus the bbb rating is not a guarantee of a business reliability or performance bbb recommends that consumers consider a business bbb rating and customer review rating in addition to all other available information about the business share your experience submit a review submit a complaint share print × claim your business by claiming your business profile businesses can add custom text or descriptive information about their services insert company logos and add photographs for consumers to view close × accreditedquestionmodal title content close × customer rating modal title content close × score modal title content close × find a location filter close bbb search database of businesses charities  news items for full functionality of this site it is necessary to enable javascript here are the instructions how to enable javascript in your web browser no results found   ask bbb to develop a report on this business by clicking here bbb search tips use bbbs search bar above to check out businesses and charities from our comprehensive database of bbb business profiles enter any of the following into the search box business or charity name website url phone number email address or select from the categories in the droplist to search by type of business or type of charity want to know more about our rating system find out more here  need more info  try the search faqs innovus pharma files its product license application in canada for the commercialization of vesele® as a natural health product to help improve symptoms of sexual dysfunctionhomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballinnovus pharma files its product license application in canada for the commercialization of vesele® as a natural health product to help improve symptoms of sexual dysfunctionbusiness wiremay  reblogsharetweetsharesan diegobusiness wireinnovus pharmaceuticals inc the “company” or “innovus pharma” otcqb venture market innv today announced that the company filed its product license application with health canada as a natural health product “npn” to market its current bestselling product vesele® with the indication to “help improve symptoms of sexual dysfunction” if accepted by health canada vesele® will be available overthecounter “otc” in  capsule bottles and will not require a prescription the product if approved will not be reimbursed by the canadian government therefore the company will be able to set the retail price as it does in the united states if approved the company expects to directly launch the product itself through its beyond human® sales and marketing platform currently being set up in canada and through other sales channelsbased on health canada’s approval process the approval process normally takes up to six  months in canada for this type of product assuming no additional information is requested by health canada“if approved by health canada for commercialization in canada vesele® will be our fourth product on the canadian market including zestra® zestra glide® and ejectdelay® sold under the name uxor™ by our partner orimed pharma” said dr bassam damaj president and chief executive officer of innovus pharma “having vesele® be an npn in canada bearing the indication of help improve symptoms of sexual dysfunction would be a great value add to the product and a great accomplishment for the company” continued dr damajvesele® is a proprietary oral formulation of larginine and lcitrulline with the natural absorption enhancer bioperine® vesele® was formulated to increase blood flow and nitric oxide productionas previously reported a us human clinical use survey was completed on vesele® to evaluate erectile dysfunction and sexual satisfaction in men using vesele® twice daily for up to four months with the following favorable results  increase in erection hardness  increase in erection maintenance  increase in desire for sexual activity  increase the ability to satisfy the partnerabout innovus pharmaceuticals incheadquartered in san diego innovus pharma is an emerging overthecounter “otc” consumer goods and specialty pharmaceutical company engaged in the commercialization licensing and development of safe and effective nonprescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases innovus pharma delivers innovative and uniquely presented and packaged health solutions through its a otc medicines and consumer and health products which we market directly b commercial partners to primary care physicians urologists gynecologists and therapists and c directly to consumers through our online channels retailers and wholesalers the company is dedicated to being a leader in developing and marketing new otc and branded abbreviated new drug application “anda” products the company is actively pursuing opportunities where existing prescription drugs have recently or are expected to change from prescription or rx to otcfor more information go to wwwinnovuspharmacom wwwzestracom wwwejectdelaycom wwwmyveselecom wwwsensumpluscom wwwmyandroferticom wwwfluticarecom wwwbeyondhumantestosteronecom wwwgetbeyondhumancom wwwtrybeyondhumancom wwwrecalmaxcom and wwwprostagorxcominnovus pharmas forwardlooking safe harborstatements under the private securities litigation reform act as amended with the exception of the historical information contained in this release the matters described herein contain forwardlooking statements that involve risks and uncertainties that may individually or mutually impact the matters herein described for a variety of reasons that are outside the control of the company including but not limited to receiving patent protection for any of its products to successfully receive approval for vesele® in canada and commercialize this product therein and commercialize other products in the us and internationally and to achieve its other development commercialization financial and staffing objectives readers are cautioned not to place undue reliance on these forwardlooking statements as actual results could differ materially from the forwardlooking statements contained herein readers are urged to read the risk factors set forth in the companys most recent annual report on form k and other filings made with the sec copies of these reports are available from the secs website or without charge from the companyview source version on businesswirecom httpwwwbusinesswirecomnewshomeenreblogsharetweetsharerecently viewedyour list is emptywhat to read nextab inbev bud earnings and revenues miss estimates in qzacksengineer finds pattern makes millions in stocksmoney morningsponsoredjeff bezos’ brief stint as world’s richest human ends with amazon’s secondquarter whifftechcrunchwill phillips  psx disappoint this earnings seasonzacksunder armour uaa to report q earnings what lies aheadzacksdiscover it  out of  avg by k customersdiscover cardsponsoredcan bp plc bp spring a surprise this earnings seasonzacksthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insiderthe real reason overseas manufacturing is coming to americayahoo financethis will be in everyones household by banyan hillsponsoredhere are the us targets north korea most likely wants to nukebusiness insiderchevron and exxon mobil have a tough path ahead nyse traderyahoo finance videostocks mixed after heavy earnings weektrunk club making sense of styletrunk clubsponsoredtrump to cops please dont be too nice while arresting thugs and dont worry about their heads when you toss them in the paddy wagonbusiness insiderwells fargo faces angry questions after new sales abuses uncoveredreutersnorth korea says nd icbm test puts entire us in rangejohn doesnt that little fat kid know that if he actually fires a missile at something other than water his country will just be annihilatedjoin the conversation  k search engine marketing sem  bing ads skip to content sign upsign in   you run your business well help find your customers bing ads can help build your business and drive your success spend  and get  in advertising credit† †offer details get  in search advertising when you spend  in bing ads coupon code class first name last name email your website url business phone required microsoft may contact you to provide updates and special offers about bing ads you can unsubscribe at any time to learn more you can read the privacy statement type the code from the image enter security code   × get  in search advertising when you spend  in bing ads †offer details offer expires december   valid only for new bing ads customers who are first party recipients of the offer email a new bing ads customer is one that has not advertised on bing ads before enter promotional coupon code and spend  applies to threshold and prepaid accounts to receive  in bing ads credits limit one promotion code per new bing ads customer promotional code must be redeemed within thirty  days of bing ads new customer account creation ad campaign costs accrued before receiving a credit as well as costs accrued after all credits are used will be charged to the payment method associated with the bing ads account if customer payment fails the coupon amount will not be applied ads will continue to run and accrue costs after any promotional credit has been used up any portion of the credit not used within ninety  days of credit redemption will expire and cant be carried over even if the bing ads customer switches their payment method offer valid only to residents of the united states in order for the offer to be valid a form of payment must be entered into your account prior to redemption of the promotional code and prior to your account going live to take advantage of the credit this offer may not be combined with any other offer promotional code coupon or discount separated redeemed for cash transferred sold or bartered microsoft in its sole discretion can close your account for any suspected coupon abuse refund of the  is not permitted see bing ads terms and conditions for more details at signup other terms and conditions may apply microsoft reserves the right to cancel change or suspend this offer at any time without notice see how bing ads works customers search customers see your ad customers contact you watch how bing ads works     × how bing ads works help more customers find you see how bing can attract customers your google adwords campaigns cant reach  million searchers on the bing network tap into  of the search marketplace get in front of searchers who spend  percent more than the average internet searcher powerful network powerful benefits reach across devicesconnect with customers looking for your business anytime anywhere on any device go global or localreach people in the bing network everywhere or focus on cities counties and areas within a certain distance from your business easy to importif youre already using another product like google adwords its easy to pull that campaign into bing ads you control your costs  free signupjoin bing ads for free and control your account at every step  only pay for clickspay just when customers click on your ad no click no charge  no minimum feestart advertising with a budget that works best for your business   the advantage we gain in cost per click gives us a great return on investment — more than  percent better than google adwords scott redgate search engine marketing manager — cj pony parts by using bing ads features like image extensions and sitelink extensions this auto parts retailer races to convert customers and beat its competition  read about driving more conversions   we might not get as much of the volume as with google adwords but the volume of the traffic that we get converts really well at a lower cost scott schult executive vice president of marketing — myrtle beach area convention and visitors bureau the myrtle beach area convention and visitors bureau uses bing ads to drive site traffic and tourism at lower cost  read about getting better roi better results for less cost thats as simple as i can make it if i look at the quality of the traffic we get for the dollars we spend on bing ads our roi is fantastic alex littlewood ceo   motoroso motoroso a market network for auto enthusiasts gets better results for less cost and reaches a highvalue audience with bing ads  read about attracting quality traffic   import your adwords campaigns save time by importing your google adwords campaigns into bing ads to get ads live quickly sign in with your microsoft account or create one to get started on bing ads from within the bing ads interface select the import from google adwords option enter your google adwords credentials and select the campaign you want to import preview your ad get found online with search engine marketing make the most of your marketing dollars and drive customers to your business see how bing ads can work for you get started today give us a few details about your business to create a bing ads account and get it up and running   sign up get started with bing ads signing up is always free faq is bing ads right for me is bing ads right for my business all types of businesses find value and success with bing ads whether youre focused on local calls and foot traffic or want to drive traffic to your website from across the country or around the world bing ads has solutions for you i already appear in search results for free why should i pay for advertising your current customers may search for your business by name aiming it easy to find you in search results but customers youve yet to reach are more likely searching for general terms that wouldnt necessarily bring up your business in search results advertising next to relevant bing search results puts your business front and center with interested customers you otherwise might not reach what is the difference between seo and sem which one is right for me search engine optimization seo is adjusting your website to improve your natural ranking in search results you cannot pay to improve your website ranking on bing or yahoo thus we often refer to these results and unpaid or organic search results clicks from seo are free but seo also requires technical expertise and involves some factors over which you have only limited control search engine marketing sem is paid advertising that appears next to or above unpaid or organic search results these paid ads are purchased through bing ads you pay for sem clicks but sem gives you more control over when your website appears on results pages and you decide how much you want to pay and you can measure which ads are working and quickly improve your results you dont have to choose between seo and sem you can do both if my time is limited should i still try bing ads yes call a bing ads specialist at and we’ll set up your first campaign for you for free we’ll give you tips on getting the most out of your ads and set you up for success we’re here to help about bing ads where does my ad appear your ads could appear on the top or to the right of bing yahoo and msn search results and you can choose to target your ads to different geographic regions times or days of the week and even demographics what determines my ad position bing ads is a payperclick ppc advertising system you bid based on how much you are willing to pay per each click on your ad because webpages have a limited number of places to show ads we auction those spaces you are bidding against other advertisers to get your ads into the space you want so if you bid on the keyword shoe you will have to beat the bids of the other advertisers who are also bidding on shoe you determine how much you are willing to bid your ad position is based on several things including how closely your ad and website fit with the terms that are searched relevance how your bid compares to other bids in the bing ads auction how strongly your ad has performed in the past and how often it has been clicked clickthrough rate the stronger you are in these areas the better your chances of winning the top ad position how to use bing ads how can i use bing ads to drive more people to my website here are some tips to get better results review your budget and bid strategy if your ad keeps pausing your budget limit may be set too low competitive bids help your ad stay in a strong position to catch eyes and get more clicks to your website expand your targeting both for location and for devices computer mobile and tablet make sure your ads and website are relevant to the keywords you bid on would someone searching your terms expect to see and ad for your business how can i keep my costs down while your first instinct may be to lower your budget first try lowering your maximum bids yes this could mean fewer customers visit your site but if you increase your quality score and build ads with a strong performance history you may be able to win a good ad position with a lower bid that would lower your costperclick and help stretch your budget how do i know if bing ads is working view a wide range of performance trends in your account to quickly see key stats ad clicks the number of times your ad appeared impressions spend average costperclick clickthrough rate average ad position cost per acquisition and conversions you can also run performance reports to get insights into how well your campaigns are doing can i run more than one ad yes in fact we encourage it only one ad will show at a time but running multiple ads lets you test different approaches to see whats working best with your target customers frequently businesses try out different ads for specific products or pages getting started with bing ads how do i get started sign up for bing ads which keywords should i choose you have a few options to help choose your keywords first youll want to think of the terms one of your customers might use to search for your products and offerings those search terms are a great starting point then you can use tools right in your account to find more keywords within bing ads click campaigns on the top of the page click the keywords tab and then click add keywords this will let you search for new keywords based on one you enter search a website for keywords search your destination urls for keywords how can i write a good ad here are a few tips that can help make your ad stand out keep your ads relevant one way to improve relevance is to use your customers most popular search terms in your ad titles and txt describe what sets your product apart use your customers language use words and writing tone that are likely to attract your typical customer be specific this clearer and more specific your offering the better for example rather than big discount specify and exact percentage such as  percent off give customers a reason to click your ad right now offer a specific call to action such as encouraging customers to request a brochure or consultation download a free ebook subscribe to a newsletter or take advantage of a limitedtime discount sign up with bing ads to get started